China’s DeepSeek claims theoretical cost-profit ratio of 545% per day

China’s DeepSeek claims theoretical cost-profit ratio of 545% per day


Lionel Bonaventure | Afp | Getty Images

Chinese AI startup DeepSeek on Saturday disclosed some cost and revenue data related to its hit V3 and R1 models, claiming a theoretical cost-profit ratio of up to 545% per day, though it cautioned that actual revenue would be significantly lower.

This marks the first time the Hangzhou-based company has revealed any information about its profit margins from less computationally intensive “inference” tasks, the stage after training that involves trained AI models making predictions or performing tasks, such as through chatbots.

The revelation could further rattle AI stocks outside China that plunged in January after web and app chatbots powered by its R1 and V3 models surged in popularity worldwide.

The sell-off was partly caused by DeepSeek’s claims that it spent less than $6 million on chips used to train the model, much less than what U.S. rivals like OpenAI have spent.

The chips DeepSeek claims it used, Nvidia’s H800, are also much less powerful than what OpenAI and other U.S. AI firms have access to, making investors question even further U.S. AI firms’ pledges to spend billions of dollars on cutting-edge chips.

DeepSeek said in a GitHub post published on Saturday that assuming the cost of renting one H800 chip is $2 per hour, the total daily inference cost for its V3 and R1 models is $87,072. In contrast, the theoretical daily revenue generated by these models is $562,027, leading to a cost-profit ratio of 545%. In a year this would add up to just over $200 million in revenue.

However, the firm added that its “actual revenue is substantially lower” because the cost of using its V3 model is lower than the R1 model, only some services are monetized as web and app access remain free, and developers pay less during off-peak hours.



Source

U.S. counterterrorism director Joe Kent resigns over war: ‘Iran posed no imminent threat’
World

U.S. counterterrorism director Joe Kent resigns over war: ‘Iran posed no imminent threat’

Joe Kent, director of the National Counterterrorism Center, testifies during the House Homeland Security Committee hearing titled “Worldwide Threats to the Homeland,” in Cannon building on Wednesday, December 11, 2025. Tom Williams | Cq-roll Call, Inc. | Getty Images National Counterterrorism Center Director Joe Kent on Tuesday announced he will resign in response to the […]

Read More
European markets need to get their act together, CEO of Norway’s  trillion wealth fund says. ‘The winner takes it all’
World

European markets need to get their act together, CEO of Norway’s $2 trillion wealth fund says. ‘The winner takes it all’

Nicolai Tangen, chief executive officer of NBIM, at the Norges Bank Climate Conference in Oslo, Norway, on Oct. 21, 2025. Naina Helén Jåma | Bloomberg | Getty Images European markets are facing a crisis and must get their act together to fix it, the head of the world’s biggest individual investor has said. Speaking to […]

Read More
Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market
World

Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market

HSBC analysts just slashed their recommendation on the world’s most valuable pharmaceutical company, Eli Lilly, signaling a potential cooling period for the red-hot obesity drug trade that has come to dominate market narratives of the sector. Analysts led by Rajesh Kumar downgraded Lilly to Reduce from Hold, cutting their target price to $850 from $1,070, […]

Read More